These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4277064)

  • 21. [On the immunitary condition among children in Savona and the diffusion of poliovirus in the 3 years following mass antipoliomyelitic vaccination].
    Deveris B; De Flora S; Di Stefano G
    G Ig Med Prev; 1968; 9(2):130-41. PubMed ID: 4314815
    [No Abstract]   [Full Text] [Related]  

  • 22. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliomyelitis in India.
    Basu RN
    Indian Pediatr; 1991 Jun; 28(6):589-92. PubMed ID: 1748506
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of poliovirus neutralizing antibodies in 108 subjects vaccinated with the Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):653-7. PubMed ID: 5997193
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral immunization against poliomyelitis in Jakarta.
    Sutedjo ; Thaib S; Harmanses S; Suharjono ; Sudijanto ; Azis A; Trenggonowati R
    Paediatr Indones; 1968; 8(5):185-91. PubMed ID: 5720565
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epidemiology of poliomyelitis in Brazil].
    Becker RA
    Rev Paul Med; 1983; 101(3):113-8. PubMed ID: 6648222
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliovirus neutralizing antibody levels among preschool children.
    Poland JD; Plexico K; Flynt JW; Chin TD
    Public Health Rep (1896); 1968 Jun; 83(6):507-12. PubMed ID: 4968129
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiological and immunity aspects of poliomyelitis in children less than a year old in an area in the region of Greater São Paulo, Brazil].
    Waldman EA; Barbosa V; Fujita M; Waldman CC; Gonzaga de Lacerda JP
    Rev Saude Publica; 1983 Feb; 17(1):9-22. PubMed ID: 6867605
    [No Abstract]   [Full Text] [Related]  

  • 29. Developing gap in immunity to poliomyelitis in an urban area.
    Melnick JL; Burkhardt M; Taber LH; Erckman PN
    JAMA; 1969 Aug; 209(8):1181-5. PubMed ID: 5819667
    [No Abstract]   [Full Text] [Related]  

  • 30. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 31. The status of poliomyelitis in Venezuela.
    Echezuría E
    Bull Pan Am Health Organ; 1974; 8(1):66-71. PubMed ID: 4371606
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].
    Assumma M; Russo V; Alemanno A
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):175-86. PubMed ID: 5615073
    [No Abstract]   [Full Text] [Related]  

  • 34. [Course of immunity in subjects repeatedly vaccinated with Sabin virus].
    Crovari P; Bori D; De Flora S
    G Ig Med Prev; 1971; 12(1):19-32. PubMed ID: 4340479
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems with oral poliovaccine in India.
    John TJ
    Indian Pediatr; 1972 May; 9(5):252-6. PubMed ID: 4649422
    [No Abstract]   [Full Text] [Related]  

  • 36. [On an epidemic outbreak of poliomyelitis, type 3, in the Voivode County of Poznań in 1968].
    Walter T
    Zentralbl Bakteriol Orig; 1969; 211(2):162-6. PubMed ID: 4318358
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serologic investigations of oral antipoliomyelitic vaccination campaigns].
    Edlinger E
    Tunis Med; 1965; 43(3):283-7. PubMed ID: 5849957
    [No Abstract]   [Full Text] [Related]  

  • 39. [Investigation of the frequency of neutralizing antibodies against poliovirus (Barcelons, 1965)].
    Pumarola A; Rodríguez-Torres A
    Microbiol Esp; 1966; 19(3):327-47. PubMed ID: 5989240
    [No Abstract]   [Full Text] [Related]  

  • 40. [Incidence of cytopathogenic enteric viruses in Lombardy 5 years after the introduction of antipoliomyelitic vaccination with the Sabin vaccine].
    Galli MG
    Ann Sclavo; 1971; 13(3):362-9. PubMed ID: 4340984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.